| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.19 | 0.03 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.18 | 6e-06 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.18 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |